PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: fjr0@cdc.gov.\', \'National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.\', \'Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Washington, DC, United States.\', \'National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0376-8716(21)00278-710.1016/j.drugalcdep.2021.108783
?:hasPublicationType
?:journal
  • Drug and alcohol dependence
is ?:pmid of
?:pmid
?:pmid
  • 34049102
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.715
?:rankingScore_hIndex
  • 142
?:title
  • Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all